The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
Clinical trial NCT00716092 · COMPLETED
Trial details
- NCT number
- NCT00716092
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-11-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.